Equities analysts expect Cardinal Health Inc (NYSE:CAH) to report $0.98 earnings per share (EPS) for the current fiscal quarter, Zacks reports. Five analysts have provided estimates for Cardinal Health’s earnings. The highest EPS estimate is $1.13 and the lowest is $0.92. Cardinal Health reported earnings per share of $1.01 during the same quarter last year, which indicates a negative year-over-year growth rate of 3%. The business is scheduled to report its next quarterly earnings report on Monday, August 5th.

According to Zacks, analysts expect that Cardinal Health will report full-year earnings of $5.09 per share for the current financial year, with EPS estimates ranging from $5.05 to $5.12. For the next fiscal year, analysts forecast that the business will report earnings of $5.23 per share, with EPS estimates ranging from $5.06 to $5.36. Zacks’ EPS calculations are a mean average based on a survey of research analysts that cover Cardinal Health.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Thursday, May 9th. The company reported $1.59 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.43 by $0.16. The company had revenue of $35.23 billion for the quarter, compared to analyst estimates of $35.09 billion. The company’s revenue was up 4.7% on a year-over-year basis. During the same quarter last year, the business earned $1.39 earnings per share.

Several brokerages have issued reports on CAH. ValuEngine upgraded shares of Cardinal Health from a “strong sell” rating to a “sell” rating in a research report on Thursday, May 9th. Zacks Investment Research downgraded shares of Cardinal Health from a “buy” rating to a “hold” rating in a research report on Tuesday, April 9th. Wolfe Research assumed coverage on shares of Cardinal Health in a research report on Tuesday, April 2nd. They issued an “underperform” rating for the company. Guggenheim assumed coverage on shares of Cardinal Health in a research report on Wednesday, April 17th. They issued a “neutral” rating and a $51.00 price target for the company. Finally, UBS Group assumed coverage on shares of Cardinal Health in a research report on Thursday, January 17th. They issued a “neutral” rating and a $51.00 price target for the company. Three equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and one has issued a buy rating to the company. The company has an average rating of “Hold” and an average target price of $56.20.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Legal & General Group Plc raised its position in Cardinal Health by 6.8% during the third quarter. Legal & General Group Plc now owns 1,846,326 shares of the company’s stock valued at $99,702,000 after purchasing an additional 117,018 shares in the last quarter. Vanguard Group Inc raised its position in Cardinal Health by 22.0% during the third quarter. Vanguard Group Inc now owns 28,021,950 shares of the company’s stock valued at $1,513,186,000 after purchasing an additional 5,058,369 shares in the last quarter. Federated Investors Inc. PA raised its position in Cardinal Health by 492.3% during the third quarter. Federated Investors Inc. PA now owns 129,705 shares of the company’s stock valued at $7,004,000 after purchasing an additional 107,807 shares in the last quarter. First Hawaiian Bank raised its position in Cardinal Health by 77.0% during the fourth quarter. First Hawaiian Bank now owns 4,095 shares of the company’s stock valued at $182,000 after purchasing an additional 1,781 shares in the last quarter. Finally, Steward Partners Investment Advisory LLC raised its position in Cardinal Health by 17.1% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 11,215 shares of the company’s stock valued at $500,000 after purchasing an additional 1,634 shares in the last quarter. Institutional investors own 87.67% of the company’s stock.

CAH stock traded up $0.35 during mid-day trading on Friday, hitting $45.58. 103,434 shares of the company were exchanged, compared to its average volume of 3,271,891. The company has a quick ratio of 0.54, a current ratio of 1.07 and a debt-to-equity ratio of 1.22. The company has a market capitalization of $13.76 billion, a PE ratio of 9.10, a price-to-earnings-growth ratio of 1.46 and a beta of 1.14. Cardinal Health has a 1-year low of $42.17 and a 1-year high of $58.31.

The firm also recently declared a quarterly dividend, which will be paid on Monday, July 15th. Stockholders of record on Monday, July 1st will be given a $0.4811 dividend. This represents a $1.92 dividend on an annualized basis and a dividend yield of 4.22%. This is an increase from Cardinal Health’s previous quarterly dividend of $0.48. The ex-dividend date of this dividend is Friday, June 28th. Cardinal Health’s payout ratio is presently 38.20%.

Cardinal Health Company Profile

Cardinal Health, Inc operates as an integrated healthcare services and products company in the United States and internationally. It provides medical products and pharmaceuticals, and solutions that enhance supply chain efficiency for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices.

See Also: What are the FAANG Stocks?

Get a free copy of the Zacks research report on Cardinal Health (CAH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.